Arsenal confirm serious knee injury and operation for Vivianne Miedema after Women’s Champions League match with Lyon

Arsenal have confirmed that Vivianne Miedema has suffered a serious knee injury and will undergo an operation after the Women’s Champions League match with Lyon.

The devastating injury for Miedema took the shine off Arsenal’s night as they qualified for the quarter-finals of the competition, despite losing to holders Lyon 1-0 in the hotly-anticipated clash.

Miedema left the field in tears on a stretcher with her leg strapped following an awkward fall on the stroke of half-time, just before Frida Maanum’s own goal gave Lyon the lead.

Barclays WSL

‘This club is home for me’ – Mead signs new Arsenal contract

16/12/2022 AT 13:26

After the match, it was still unclear how serious Miedema’s injury was, but that has now become clear and Arsenal have taken the moment to provide an update and pledge their support for the star player.

A club statement read: “We can confirm that Vivianne Miedema suffered a ruptured anterior cruciate ligament during our UEFA Women’s Champions League match against Lyon at Emirates Stadium on Thursday.

“Viv will undergo surgery in the coming days and will, unfortunately, be ruled out for an extended period of time.

“A more detailed timescale will be established once the operation is complete.

“Everyone at Arsenal wishes Viv well in her recovery and will be providing her with all the support she needs to return to action as soon as possible.”

Arsenal will conclude their Group C campaign with a match against Zurich on December 21, knowing victory will guarantee them the top spot in Group C.

Lyon will progress with a point against Juventus on the final day of the group stage, with the Italian champions keeping their hopes of progression alive with a 5-0 win over Zurich.

Women’s Champions League

Arsenal progress but lose Miedema to concerning injury

15/12/2022 AT 23:11

Ballon d’Or

Miedema critical of Ballon d’Or, says she didn’t ‘feel appreciated’

14/12/2022 AT 14:50

Read the full article Here

Leave a Reply

Your email address will not be published. Required fields are marked *

DON’T MISS OUT!
Subscribe To Newsletter
Be the first to get latest updates and exclusive content straight to your email inbox.
Stay Updated
Give it a try, you can unsubscribe anytime.
close-link